Here are the 424B prospectus supplements from Recovery Inc A (MSPR) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow MSPR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MSPR filings page.
MSP Recovery, Inc. files a Prospectus Supplement and attached Form 8-K describing a resale registration and short-term funding arrangements. The prospectus registers up to 909,982 shares of Class A common stock, up to 755,200,000 warrants, and up to 236,019 shares issuable upon warrant exercise. The supplement clarifies that Public Warrants have an adjusted exercise price of $0.4375 and New Warrants carry an exercise price of $50,312.50. The document also discloses two one-time advances: a $0.1 million discretionary advance from Hazel Partners Holdings, LLC to increase the Operational Collection Floor, and a $0.1 million one-time advance of recovery proceeds from VRM MSP Recovery Partners, LLC, each described as standalone accommodations with no commitment for further funding.
MSP Recovery, Inc. filed Prospectus Supplement No. 59 registering 285,715 shares of Class A common stock for potential resale or issuance to YA II PN, Ltd. (Yorkville) under a Standby Equity Purchase Agreement (the “Yorkville SEPA”). The supplement attaches a Form 8-K that discloses recent amendments to the Yorkville facility, multiple Convertible Notes advances and conversion terms, reductions to the SEPA Floor Price down to $0.50, a Nasdaq delisting and transition to OTCQB, and two one-time short-term advances of $0.1 million each from Hazel and VRM to support operations. The Yorkville SEPA provides up to $250 million of issuance capacity subject to an Ownership Limitation (9.99%) and previously an Exchange Cap that was lifted effective January 8, 2025. The company states it will not receive proceeds from Yorkville’s resale activity, though it may elect to sell shares to Yorkville under the SEPA.
MSP Recovery, Inc. registers 285,715 shares of Class A Common Stock for resale by a selling securityholder under its prospectus supplement dated March 23, 2026. The shares were or may be issued to YA II PN, Ltd. ("Yorkville") pursuant to a Standby Equity Purchase Agreement (the "Yorkville SEPA").
The Yorkville SEPA contemplates up to $250 million of Class A Common Stock issuances subject to a 9.99% Ownership Limitation and an Exchange Cap that was effectively lifted January 8, 2025. Yorkville also provided convertible promissory notes with various conversion mechanics and a Floor Price floor that was reduced over time to a $0.50 Floor Price. The Company will not receive proceeds from Yorkville's resale of shares; proceeds from any direct sales to Yorkville under the SEPA would accrue to the Company.
MSP Recovery, Inc. registers the resale by selling securityholders of up to 32,220 shares of its Class A Common Stock, adjusted for a 1-for-7 reverse split. The registration includes up to 15,239 shares issuable upon exercise of a warrant (the CPIA Warrant).
The prospectus supplement notes that should the CPIA Holder exercise the CPIA Warrant, the Company would only receive nominal proceeds because the exercise price is $0.4375 per share. The filing also attaches a Current Report describing two one-time advances totaling $0.2 million from Hazel and VRM to provide near-term liquidity; these advances are standalone accommodations and do not create ongoing funding commitments.
MSP Recovery, Inc. files a prospectus supplement to register up to 909,982 shares of Class A Common Stock, up to 755,200,000 warrants to purchase Class A Common Stock, and up to 236,019 shares issuable upon exercise of warrants.
The supplement describes resale by selling securityholders of various share groups (Founder Shares, Private Units, Up-C exchangeable shares and other contract issuances) and discloses that cash proceeds to the company are expected to be nominal from the Public Warrants (less than $500) and that the company will not retain proceeds from the New Warrants. The filing also attaches a Form 8-K disclosing one-time advances: a $0.1 million discretionary Operational Collection Floor advance from Hazel Partners Holdings, LLC and a $0.1 million one-time advance of recovery proceeds from VRM MSP Recovery Partners, LLC; both advances are described as standalone, discretionary accommodations and do not create ongoing committed liquidity.
MSP Recovery, Inc. files a prospectus supplement registering 56,896 shares of Class A Common Stock for resale.
The supplement states the registered shares include 28,572 shares issuable upon exercise of VRM Warrants, 2,858 issued and 14,286 issuable to VRP, and 11,180 issued to Palantir. The VRM and VRP warrants have a $0.0175 exercise price, producing only nominal proceeds if exercised.
The filing also discloses two one-time advances: a $0.1 million advance from Hazel Partners (March 23, 2026) and a $0.1 million recovery-proceeds advance from VRM (March 20, 2026), each described as standalone accommodations with no commitment for further funding.
MSP Recovery, Inc. amends its prospectus to register up to 909,982 shares of Class A Common Stock, up to 755,200,000 New Warrants, and up to 236,019 shares issuable upon warrant exercises, for resale by selling securityholders.
The supplement discloses that Public Warrants (exercise price $0.4375) are likely to be exercised but would generate nominal proceeds, while New Warrants (exercise price $50,312.50) are unlikely to be exercised given the market price. The filing also reports two one-time advances—$0.2M from Hazel Partners and $0.2M from VRM—to provide short-term liquidity, and the resignations of a director and the CFO (February 2026).
MSP Recovery, Inc. files a prospectus supplement registering up to 32,220 shares of Class A common stock for resale by selling securityholders, including up to 15,239 shares issuable upon exercise of a CPIA Warrant.
The supplement attaches a Form 8-K describing two one-time advances of $0.2 million each from Hazel Partners Holdings, LLC and VRM MSP Recovery Partners, LLC to support operations and accounts payable, respectively, and states the Hazel advance is discretionary and does not reopen facility capacity. The filing discloses the resignation of director Ophir Sternberg and CFO Francisco Rivas-Vasquez, and notes a 1-for-7 reverse split effective September 1, 2025. Share and per-share figures in the supplement are adjusted for the reverse split.
MSP Recovery, Inc. is registering 285,715 shares of Class A Common Stock for resale by a selling securityholder under Prospectus Supplement No. 57.
The resale registration covers shares originally issued or issuable to YA II PN, Ltd. (Yorkville) under the Standby Equity Purchase Agreement (the Yorkville SEPA). The Yorkville SEPA contemplates purchases of up to $250 million of Class A Common Stock, but is subject to an Ownership Limitation of 9.99% and an Exchange Cap that was effectively lifted January 8, 2025. The prospectus supplement incorporates the Company’s Form 8-K disclosure, which also describes Yorkville Convertible Notes with aggregate advances and specified conversion pricing and a variety of amendments to pricing floors, maturities, and other terms.
MSP Recovery, Inc. files a prospectus supplement to register 56,896 shares of Class A common stock for resale by selling securityholders, including warrants and shares issued to Virage entities and Palantir, adjusted for a 1-for-7 reverse split.
The supplement attaches a Form 8-K that discloses two short-term one-time advances: a $0.2 million discretionary advance from Hazel Partners under the existing working capital facility and a $0.2 million one-time advance from VRM to support accounts payable, each described as non-recurring and not creating ongoing funding commitments. The 8-K also reports the immediate resignations of director Ophir Sternberg and CFO Francisco Rivas-Vasquez.
MSP Recovery, Inc. files a prospectus supplement covering the resale of up to 909,982 shares of Class A common stock and up to 755,200,000 warrants, plus the issuance of up to 236,019 shares upon warrant exercise. The supplement also attaches a new current report.
The report describes a $250,000 one-time advance under the discretionary Working Capital Credit Facility with Hazel Partners Holdings LLC, to be used primarily for operating expenses. The company stresses this advance is a standalone accommodation that does not reinstate or reopen availability, creates no commitment for future funding, and provides no ongoing liquidity, and states it has no reasonable basis to expect further advances under the facility.
MSP Recovery, Inc. filed a prospectus supplement covering the resale of up to 56,896 shares of Class A common stock by selling securityholders. The shares include stock issued or issuable to Virage-affiliated entities under prior agreements and 11,180 shares issued to Palantir Technologies as compensation for products and services. Warrants tied to part of these shares have a low $0.0175 per share exercise price, so any cash the company receives from exercises would be only nominal.
Attached to the supplement, MSP Recovery reported a new letter agreement with Hazel Partners Holdings under its existing working capital credit facility. Hazel funded a one-time $250,000 advance on January 26, 2026 to be used primarily for operating expenses, increasing the Operational Collection Floor beyond its prior level. The company emphasizes this is a standalone accommodation, does not restore ongoing availability, and that it has no rights to, and no reasonable basis to expect, further advances or committed liquidity under this facility.
MSP Recovery, Inc. has filed a prospectus supplement covering the resale, from time to time, of up to 32,220 shares of Class A Common Stock by existing holders, including 15,239 shares issuable upon exercise of a CPIA Warrant at $0.4375 per share, which would generate only nominal proceeds if exercised.
The supplement also incorporates a new agreement under which Hazel Partners Holdings LLC provided a one-time $250,000 advance under the company’s discretionary working capital credit facility, primarily for operating expenses. The company emphasizes this is a standalone accommodation, does not restore ongoing borrowing capacity, and that it has no rights to and no reasonable basis to expect further advances under the facility.
MSP Recovery, Inc. filed a prospectus supplement registering up to 285,715 shares of Class A common stock for resale by Yorkville under an existing standby equity purchase agreement. The company will not receive proceeds from Yorkville’s resale of these shares, though it may receive cash when it elects to sell stock to Yorkville under the facility.
The attached current report also discloses a $250,000 one-time advance under MSP Recovery’s working capital credit facility with Hazel Partners Holdings. This advance is fully discretionary, does not reinstate borrowing capacity, and the company states it has no rights to and no reasonable basis to expect further funding under that facility, highlighting continued liquidity pressure alongside prior Nasdaq delisting and OTCQB trading.
MSP Recovery, Inc. filed a prospectus supplement covering up to 285,715 shares of Class A common stock that it may issue and sell to YA II PN, Ltd. (Yorkville) under a standby equity purchase agreement, with Yorkville then eligible to resell those shares from time to time. The Yorkville facility permits equity sales at discounts to market VWAP, subject to a 9.99% ownership cap, while prior stockholder approval has lifted an earlier exchange cap on issuance limits.
The supplement also includes a current report describing a new letter agreement under which Hazel Partners Holdings LLC, the lender under MSP Recovery’s working capital credit facility, made a one-time discretionary advance of $300,000 for operating expenses. The company states this advance does not reinstate or reopen ongoing borrowing capacity, emphasizes that the facility remains fully discretionary with no committed liquidity or borrowing base, and notes it has no rights to, or reasonable basis to expect, further advances from Hazel.
MSP Recovery, Inc. files a prospectus supplement covering the resale of up to 909,982 shares of Class A common stock and up to 755,200,000 warrants, plus the issuance of up to 236,019 shares upon warrant exercise. The Public Warrants have a reduced exercise price of $0.4375 per share, while the New Warrants carry a much higher $50,312.50 per share exercise price, which the company states makes exercises unlikely at recent market prices, and it does not expect to rely on New Warrant exercises for cash. As context, on January 21, 2026, the stock closed at $0.067 per share following a 1-for-7 reverse split. Separately, the company discloses a one-time $300,000 advance under its working capital facility with Hazel Partners Holdings LLC, solely for operating expenses, and emphasizes that this is a standalone accommodation with no commitment or reasonable basis to expect further funding.
MSP Recovery, Inc. has filed a prospectus supplement covering the resale of up to 56,896 shares of Class A common stock by selling securityholders. These include shares and warrants held by Virage Recovery Master LP, Virage Recovery Participation LP, and Palantir Technologies, Inc., with certain shares issuable upon exercise of warrants at an exercise price of $0.0175 per share, which would yield only nominal proceeds to the company if exercised.
The supplement also attaches a current report describing a new letter agreement with Hazel Partners Holdings LLC, under which Hazel made a one-time $300,000 advance under the existing working capital credit facility to be used solely for operating expenses. The company states this advance is a standalone accommodation, does not restore or expand ongoing availability under the facility, and that it has no rights to, and no reasonable basis to expect, any further advances.
MSP Recovery, Inc. filed a prospectus supplement covering the potential resale, from time to time, of up to 32,220 shares of its Class A common stock by selling securityholders, including up to 15,239 shares issuable upon exercise of the CPIA Warrant at an exercise price of $0.4375 per share. Any proceeds from sales will go to the selling securityholders, while the company would receive only nominal cash if the CPIA Warrant is exercised.
The company also disclosed that Hazel Partners Holdings LLC agreed to make a one-time $300,000 advance under its discretionary working capital credit facility to be used solely for operating expenses. This advance, funded on January 20, 2026, is described as a standalone accommodation that does not restore or expand ongoing borrowing availability and does not create any commitment for future funding.
MSP Recovery, Inc. has filed a prospectus supplement covering the resale of up to 56,896 shares of Class A common stock by existing holders. The shares include stock already issued to Virage-affiliated entities and Palantir Technologies, plus shares issuable upon exercise of low-priced warrants at $0.0175 per share, from which the company would receive only nominal proceeds.
The attached current report explains that a Nasdaq Hearings Panel has denied the company’s appeal of prior staff determinations, and the company’s common stock will be delisted from Nasdaq for failing to meet minimum stockholders’ equity of $2.5 million and a $1.00 bid price. Trading of the common stock is expected to continue on the OTCQB market under the ticker “MSPR.” The company also notes a 1-for-7 reverse stock split effective September 1, 2025, and all share figures reflect this split.
MSP Recovery, Inc. has registered for resale up to 32,220 shares of Class A common stock held by existing investors, including 15,239 shares issuable upon exercise of a CPIA Warrant with a per-share exercise price of $0.4375, from which the company would receive only nominal cash proceeds.
The prospectus supplement also incorporates a new report that the company’s common stock will be delisted from Nasdaq after it failed to meet the minimum stockholders’ equity requirement of $2.5 million and the minimum $1.00 bid price rule. Trading is expected to shift to the OTCQB market under the same “MSPR” ticker. A 1-for-7 reverse stock split effective September 1, 2025 is reflected in all share data.
MSP Recovery, Inc. updates its shelf prospectus to cover the resale by existing holders of up to 909,982 shares of Class A common stock, 755,200,000 warrants, and the potential issuance of up to 236,019 additional shares upon warrant exercise. The filing explains that Public Warrants, exercisable at $0.4375 per share, would generate less than $500 if fully exercised, while over 1.0 billion New Warrants carry a $50,312.50 per share exercise price and would not provide retained proceeds to the company, so operations are expected to rely on other cash sources. The company also notes a prior 1-for-7 reverse stock split effective September 1, 2025. In the attached current report, MSP Recovery discloses that a Nasdaq Hearings Panel has denied its appeal, and the company’s common stock will be delisted from Nasdaq for not meeting minimum stockholders’ equity of $2.5 million and the $1.00 minimum bid price, with trading expected to continue on the OTCQB market under the symbol “MSPR.”
MSP Recovery, Inc. is updating a resale registration covering up to 909,982 shares of Class A common stock, related warrants, and up to 236,019 shares issuable upon warrant exercise. These securities may be sold from time to time by existing holders; the company itself would receive only nominal cash (less than $500) from Public Warrant exercises and no cash from New Warrant exercises. A 1-for-7 reverse stock split took effect on September 1, 2025, and all share figures reflect this change.
The attached quarterly report shows very limited liquidity and heavy losses. As of September 30, 2025, MSP Recovery held cash of $1.8 million against total liabilities of $2.40 billion and reported a stockholders’ deficit of $563.8 million. For the first nine months of 2025, revenue was $1.6 million and the net loss was $723.3 million, driven largely by claims amortization and interest expense.
The company discloses “substantial doubt” about its ability to continue as a going concern and notes dependence on the Yorkville standby equity facility and a fully drawn Hazel working capital facility. It warns that, without new funding, it may need to pursue insolvency or U.S. bankruptcy protection. Nasdaq has issued a delisting determination for failing the minimum equity requirement, and MSP Recovery is appealing at a hearing scheduled for December 11, 2025; if unsuccessful, the stock is expected to move to the OTCQB market.
MSP Recovery, Inc. filed a prospectus supplement covering the resale of up to 32,220 shares of Class A common stock by existing holders, including 15,239 shares issuable upon exercise of the low-priced CPIA warrant at $0.4375 per share, from which the company would receive only nominal proceeds. The supplement incorporates the company’s Q3 2025 results.
For the quarter ended September 30, 2025, MSP Recovery generated $0.2 million in revenue and recorded a net loss of $245.5 million, contributing to a nine‑month net loss of $723.3 million. As of September 30, 2025, the company reported cash of about $1.8 million, total assets of $1.55 billion, total liabilities of $2.40 billion, and a stockholders’ deficit of $563.8 million, with total equity of $(844.4) million. Management states there is substantial doubt about its ability to continue as a going concern, given heavy dependence on Yorkville financing and constrained access to other funding.
The company executed a 1‑for‑7 reverse stock split effective September 1, 2025 and faces listing pressure. Nasdaq has issued a delisting determination for failure to meet the minimum equity requirement, and MSP Recovery has requested a hearing scheduled for December 11, 2025. If it cannot maintain its Nasdaq listing, it expects its shares to trade on the OTCQB market.
MSP Recovery, Inc. (MSPR) has filed a prospectus supplement registering the resale of up to 56,896 shares of Class A common stock held by existing investors, including shares issuable upon low-priced VRM and VRP warrants, from which the company would receive only nominal cash if exercised. The supplement attaches the latest quarterly report, which shows severe financial stress, including an operating loss of $375.5 million and a net loss of $723.3 million for the nine months ended September 30, 2025.
As of that date, MSP Recovery had $1.8 million of cash, a stockholders’ deficit of $563.8 million, and total liabilities of $2.4 billion, along with a large guaranty obligation tied to its Virage financing. Management discloses “substantial doubt” about the company’s ability to continue as a going concern, noting dependence on the Yorkville standby equity facility and fully drawn Hazel credit lines, and warning that failure to secure funding could lead to insolvency or bankruptcy proceedings. The company has also received a Nasdaq delisting determination over minimum equity requirements and plans to argue for continued listing, while shares may move to the OTCQB if delisted.
MSP Recovery, Inc. is registering up to 285,715 shares of Class A common stock for resale by Yorkville under a standby equity purchase agreement. The company may sell shares to Yorkville under this facility, but will not receive proceeds from Yorkville’s resales.
The Yorkville SEPA allows MSP Recovery to sell up to $250 million of stock, supported by multiple Yorkville convertible notes with principal commitments exceeding $18 million. MSP Recovery relies on this arrangement as its primary near‑term funding source. As of September 30, 2025, it held only $1.8 million in cash and reported a nine‑month net loss of $723.3 million, driven largely by claims amortization and $374.0 million of interest expense.
Stockholders’ equity was a deficit of $563.8 million, and management states there is substantial doubt about the company’s ability to continue as a going concern absent additional capital or much higher revenue. MSP Recovery has also received a Nasdaq delisting determination due to failing the minimum equity listing standard and has requested a hearing to seek continued listing.